| 摘要: |
| 2015年5月政府放开多年对药品市场的价格管制，实施以市场定价的价格机制。国内学者对药品价格改革进行了广泛的讨论，但缺少对药品价格改革政策效应的实证研究。本文使用对2011年1月到2017年2月国内外药品价格相关指数构建双重差分模型，论证药品价格改革对药品价格的政策效应。实证结果证明，药品价格改革提高了国内药品价格和价格的波动率。从短期政策效果来看，药品价格改革的确不能降低药品价格，减轻民众医疗负担。但从经济学的角度来看，市场定价带来的市场竞争能够在长期内形成合理的药品价格，对医疗市场发展起到积极的作用。 |
| 关键词: |
| DOI： |
|
| 基金项目: |
|
| Policy Effect of Chinese Pharmaceutical Price Reform Based on Difference-in-difference Model |
|
| () |
| Abstract: |
| In May 2015, the Chinese Government removes pharmaceutical price regulation which continues for several years and implements market pricing mechanism. Researchers discuss the reform widely without marking any empirical analysis about the policy effect of the reform. This paper constructs difference-in-difference model by using pharmaceutical related price indexes between January 2011 and February 2017 and studies the policy effect of pharmaceutical price reform. The result shows that the reform does raise domestic pharmaceutical price and the volatility of the price as well. In the short-term, the reform could not reduce pharmaceutical price and release medical burden. However, from the aspect of economy, market pricing brings market competition which could form a reasonable pharmaceutical price in the long-run and have positive impacts on the development of medical market |
| Key words: |
